Latest News
Daily cannabis news and breaking stories from markets, policy, and medical sectors worldwide.
Latest News · page 3
- M&A Activity
Aurora Buys UK Pharmacy and Import Licence for £2.1m, Securing ‘Direct Route’ to Patients
As Aurora faces down an unsolicited takeover bid from one of the world’s largest cannabis companies, it has continued to expand its reach in what it sees as the markets of the near future.
- M&A Activity
Aurora Accuses Curaleaf of ‘Pressuring Shareholders’ as it Launches Official Takeover Bid
Curaleaf Holdings has pushed ahead with its unexpected and unsolicited acquisition campaign of Aurora Cannabis and has now submitted an official bid for its Canadian rival.
- Patient Access
Germany’s Medical Cannabis Insurance Reform Descends Into Chaos as Regulators Turn on Each Other
Last month, the German government passed a controversial cost-saving law that saw tens of thousands of patients denied access medical cannabis to flower reimbursed through statutory health insurance (GKV).
- M&A Activity
Argent Biopharma’s CannEpil to Target $3bn Veterinary Pain Market, Weeks After Debt-Relief Deal
Argent Biopharma’s (RGT) flagship CannEpil cannabis drug is set to pivot into the veterinary market, just weeks after it signed away the commercial rights in exchange for debt relief.
- Hemp Industry
US Hemp Industry Wins a Stay of Execution as Senate Delays Ban Until December
The US hemp industry has successfully bought itself some additional time to find a permanent solution to the incoming federal ban.
- Interviews
Cannabis Opportunity ‘Greater Today’ Than in 2019, Says the Lender Who Has Committed $550m
Just over a month ago, one of the most interesting and potentially consequential hearings in the history of US cannabis policy began.
- UK & Europe
Spain’s Tobacco Crackdown Could Quietly Wipe Out Its Cannabis Clubs
Last week, Spain’s government approved a draft tobacco law that never once mentions cannabis, yet could dismantle the everyday activity of the country’s thriving cannabis social clubs.
- Patient Access
‘Everything in Our Power’: German Patient Groups Fight to Overturn Cannabis Insurance Cuts
Earlier this month (July 10, 2026), the German government voted through a sweeping set of provisions set to significantly impact medical cannabis patients who have their prescriptions covered by their statutory health insurance.
- CBD Market
CBD Brand Director Sentenced for Covid Loan Fraud and Money Laundering
The director of UK CBD brand Virtutum Limited, which traded as CBD Asylum in Hull, has been given a suspended prison sentence for fraud and money laundering.
- Hemp Industry
Bipartisan Bill Seeks to Overturn Intoxicating Hemp Ban and Regulate Multi-Billion Dollar Sector
The US intoxicating hemp market, thought to be worth around $28bn in annual sales, could yet be saved from a devastating ban set to be implemented in a matter of months.
- Medical Cannabis
Measuring What Matters: Why Outcomes Will Decide the Future of Cannabis Medicine
The UK medical cannabis sector has spent seven years arguing for access.
- Pharmaceutical
Ananda Pharma Doses First Patient in NIHR-Backed CIPN Trial
Ananda Pharma has dosed the first patient in the ACTiON trial, a Phase 2 NIHR-funded study evaluating MRX1, the company’s proprietary CBD-based oral solution, as a treatment for chemotherapy-induced peripheral neuropathy (CIPN), a debilitating nerve-damage condition caused by chemotherapy for which no effective therapies currently exist.
